Document is current
Any future updates will be listed below
-
Authors
-
Funding
Funding for this research was provided by:
Universität zu Köln (413543196)
Universitätsklinikum Köln
- License Information
-
More Information
Article History
Accepted: 12 August 2022
First Online: 27 September 2022
Declarations
:
: <b>TK</b>: Remunerations for lectures from Janssen/Actelion.<b>PB</b>: Speaker honoraria and consultant fees from Sanofi-Genzyme, AstraZeneca, Alexion, Bayer, Travere, Pfizer, Novartis, Roche; research funding from the German Research Foundation BR-2955/8.<b>SR</b>: Remunerations for lectures and/or consultancy from Abbot, Janssen/Actelion, Arena, Bayer, BMS, GSK, MSD, Novartis, Pfizer, and United Therapeutics and grants to institution from Actelion, Bayer, Novartis, and United Therapeutics.
: This article does not contain any studies with human or animal subjects performed by any of the authors.
